A Phase I Study of Triapine (R) in Combination With Doxorubicin in Refractory Tumors

Trial Profile

A Phase I Study of Triapine (R) in Combination With Doxorubicin in Refractory Tumors

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Feb 2016

At a glance

  • Drugs Doxorubicin (Primary) ; OCX 191 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Aug 2008 Actual end date (July 2008) added as reported by ClinicalTrials.gov.
    • 24 Aug 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Aug 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top